Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

S1900G, “A Randomized Phase II Study of INC280 (capmatinib) plusOsimertinib with or without Ramucirumab in Participants with EGFR-Mutant, METAmplifiedStage IV or Recurrent Non-Small Cell Lung Cancer (Lung-MAP Sub-Study)”


Collapse Overview 
Collapse sponsor award id
S1900G


Collapse Biography 

Collapse Time 
Collapse start date
2023-04-24

Collapse end date
2033-04-23